Development of novel cationic chitosan-and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5501-5516

  Sanna, Vanna ^a   Roggio, Anna Maria ^a   Siliani, Silvia ^a   Piccinini, Massimo ^a   Marceddu, Salvatore ^b   Mariani, Alberto ^c   Sechi, Mario ^c  

^a Porto Conte Ricerche Srl   (Italy)

^b INSTITUTE OF SCIENCES OF FOOD PRODUCTION   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

Author keywords

Alginate; Chitosan; Nanochemoprevention; Nanoparticles; PLGA; Resveratrol

Indexed keywords

ALGINIC ACID; CHITOSAN; NANOCARRIER; NANOPARTICLE; POLYGLACTIN; RESVERATROL; CATION; NANOCAPSULE; RADIOPROTECTIVE AGENT; STILBENE DERIVATIVE;

ARTICLE; CHEMICAL PARAMETERS; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG COATING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION EFFICIENCY; IN VITRO STUDY; LIGHT EXPOSURE; NANOENCAPSULATION; PARTICLE SIZE; RAMAN SPECTROMETRY; SWELLING PROPERTY; ZETA POTENTIAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; LIGHT; RADIATION EXPOSURE;

RICE STRIPE VIRUS;

CATIONS; CHITOSAN; DELAYED-ACTION PREPARATIONS; DIFFUSION; LIGHT; NANOCAPSULES; PARTICLE SIZE; POLYGLACTIN 910; RADIATION-PROTECTIVE AGENTS; STILBENES;

EID: 84868282379     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79(5):727-747.
2. Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L. Dietary poly-phenols and the prevention of diseases. Crit Rev Food Sci Nutr. 2005; 45(4):287-306.
3. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr. 2005;81(Suppl 1):215S-217S.
4. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003;3(10):768-780.
5. Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal. 2008;10(3): 475-510.
6. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr. 2001;21:381-406.
7. Frémont L. Biological effects of resveratrol. Life Sci. 2000;66(8):663-673.
8. Sun AY, Wang Q, Simonyi A, Sun GY. Botanical phenolics and neurode-generation. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Boca Raton: CRC Press; 2011.
9. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337-342.
10. Campagna M, Rivas C. Antiviral activity of resveratrol. Biochem Soc Trans. 2010;38(Pt 1):50-53.
11. Yan Y, Gao YY, Liu BQ, Niu XF, Zhuang Y, Wang HQ. Resveratrol-induced cytotoxicity in human Burkitt's lymphoma cells is coupled to the unfolded protein response. BMC Cancer. 2010;10:445.
12. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004;24(5A):2783-2840.
13. Goswami SK, Das DK. Resveratrol and chemoprevention. Cancer Lett. 2009;284(1):1-6.
14. Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res. 2001;7(5):1466-1473.
15. Signorelli P, Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem. 2005; 16(8):449-466.
16. Lu Z, Cheng B, Hu YL, Zhang YH, Zou GL. Complexation of resveratrol with cyclodextrins: solubility and antioxidant activity. Food Chem. 2009;113(1):17-20.
17. Juan ME, Buenafuente J, Casals I, Planas JM. Plasmatic levels of transresveratrol in rats. Food Res Int. 2002;35(2):195-199.
18. Munin A, Edwards-Lévy F. Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics. 2011;3(4):793-829.
19. Amri A, Chaumeil JC, Sfar S, Charrueau C. Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release. 2012;158(2):182-193.
20. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83(5):761-769.
21. Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev. 2008;60(15):1615-1626.
22. Ranganathan R, Madanmohan S, Kesavan A, et al. Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications. Int J Nanomedicine. 2012;7: 1043-1060.
23. Siddiqui IA, Adhami VM, Bharali DJ, et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res. 2009; 69(5):1712-1716.
24. Sanna V, Pintus G, Roggio AM, et al. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. J Med Chem. 2011;54(5):1321-1332.
25. Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A. 1998;95(8):4607-4612.
26. Sanna V, Sechi M. Nanoparticle therapeutics for prostate cancer treatment. Maturitas. 2012;73(1):27-32.
27. Sanna V, Roggio AM, Posadino AM, et al. Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization and cytotoxicity studies. Nanoscale Res Lett. 2011;6(1):260.
28. Siddiqui IA, Mukhtar H. Nanochemoprevention by bioactive food components: a perspective. Pharm Res. 2010;27(6):1054-1060.
29. Siddiqui IA, Adhami VM, Chamcheu JC, Mukhtar H. Impact of nanotecnology in cancer: emphasis on nanochemoprevention. Int J Nanomedicine. 2012;7:591-605.
30. Sanna V, Sechi M. Nanoparticle therapeutics for prostate cancer treatment. Nanomedicine. 2012;8 Suppl 1:S31-S36.
31. Siddiqui AI, Shukla Y, Mukhtar H. Nanoencapsulation of natural products for chemoprevention. J Nanomed Nanotechnol. 2011; 2:104e.
32. Shao J, Li X, Lu X, et al. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf B Biointerfaces. 2009;72(1):40-47.
33. Teskac K, Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm. 2010;390(1):61-69.
34. Caddeo C, Teskac K, Sinico C, Kristl J. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm. 2008;363(1-2):183-191.
35. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28(1):5-24.
36. Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3): 1377-1397.
37. Davaran S, Rashidi MR, Pourabbas B, Dadashzadeh M, Haghshenas NM. Adriamycin release from poly(lactideco-glycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization. Int J Nanomedicine. 2006;1(4):535-539.
38. Li SH, Cai SX, Liu B, Ma KW, Wang ZP, Li XK. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor. Acta Pharmacol Sin. 2006;27(6):754-759.
39. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan a review. J Control Release. 2006;114(1):1-14.
40. Agrawal P, Strijkers GJ, Nicolay K. Chitosan-based systems for molecular imaging. Adv Drug Deliv Rev. 2010;62(1):42-58.
41. Takka S, Gürel A. Evaluation of chitosan/alginate beads using experimental design: formulation and in vitro characterization. AAPS Pharm Sci Tech. 2010;11(1):460-466.
42. Zhou J, Romero G, Rojas E, Ma L, Moya S, Gao C. Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and folic acid binding to achieve selective cell targeting. J Colloid Interface Sci. 2010;345(2):241-247.
43. Wang Q, Jamal S, Detamore MS, Berkland C. PLGA-chitosan/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cells. J Biomed Mater Res A. 2011;96(3):520-527.
44. Choi DH, Park CH, Kim IH, Chun HJ, Park K, Han DK. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system. J Control Release. 2010;147(2):193-201.
45. Sun B, Ribes AM, Leandro MC, Belchior AP, Spranger MI. Stilbenes: quantitative extraction from grape skins, contribution of grape solids to wine and variation during wine maturation. Anal Chim Acta. 2006; 563(1-2):382-390.
46. Elgindy N, Elkhodairy K, Molokhia A, ElZoghby A. Biopolymeric nanoparticles for oral protein delivery: design and in vitro evaluation. J Nanomed Nanotechnol. 2011;2(3):110.
47. López-Hernández J, Paseiro-Losada P, Sanches-Silva AT, Lage-Yusty MA. Study of the changes of trans-resveratrol caused by ultraviolet light and determination of transand cis-resveratrol in Spanish white wines. Eur Food Res Technol. 2007;225:789-796.
48. Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E. Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm. 1998;24(12): 1113-1128.
49. Guo C, Gemeinhart RA. Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles. Eur J Pharm Biopharm. 2008;70(2):597-604.
50. Mahmoodi M, Khosroshahi ME, Atyabi F. Laser thrombolysis and in vitro study of tPA release encapsulated by chitosan coated PLGA nanoparticles for AMI. Int J Biol Biomed Eng. 2010;4(2):35-42.
51. Michler GH, Baltá Calleja FJ. Part III Nano-and microcomposites: interphase. In: Karger-Kocsis J, Fakirov S, editors. Nanoand Micromechanics of Polymers Blends and Composites. Cincinnati: Hanser; 2009.
52. Somasundaran P, Mehta SC, Yu X, Krishnakumar S. Cap 6: colloid systems and interfaces stability of dispersions through polymer and surfactant adsorption. In: Birdi KS, editor. Handbook of Surface and Colloid Chemistry. 3rd ed. Boca Raton: CRC Press; 2008.
53. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70(1-2):1-20.
54. Zheng CH, Gao JQ, Zhang YP, Liang WQ. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres. Biochem Biophys Res Commun. 2004;323(4): 1321-1327.
55. Trimaille T, Pichot C, Delair T. Surface functionalization of poly(D,L-lactic acid) nanoparticles with poly(ethylenimine) and plasmid DNA by the layer-by-layer approach. Colloids Surf A Physicochem Eng Asp. 2003;221(1):39-48.
56. Riou V, Vernhet A, Doco T, Moutounet M. Aggregation of grape seed tannins in model wine effect of wine polysaccharides. Food Hydrocoll. 2002;16(1):17-23.
57. Handique JG, Baruah JB. Polyphenolic compounds: an overview. React Funct Polym. 2002;52:163-188.
58. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization. Eur J Pharm Biopharm. 2007;65(2):215-232.
59. Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW. A novel pHsensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Release. 2004;96(2):285-300.
60. Sartori C, Finch DS, Ralph B. Determination of the cation content of alginate thin films by FTIR spectroscopy. Polymer. 1997;38(1): 43-51.
61. Socrates G. Infrared and Raman Characteristic Group Frequencies: Tables and Charts. 3rd ed. Chichester: J Wiley & Sons; 2001.
62. Wan Y, Lu X, Dalai S, Zhang J. Thermophysical properties of polycaprolactone/chitosan blend membranes. Thermochim Acta. 2009; 487(1-2):33-38.
63. Fernández-Hervás MJ, Holgado MA, Fini A, Fell JT. In vitro evaluation of alginate beads of a diclofenac salt. Int J Pharm. 1998;163(1-2): 23-34.
64. Lee CW, Yen FL, Huang HW, et al. Resveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and anti-inflammatory pathways. J Agric Food Chem. 2012;60(18):4662-4671.
65. Tzeng CW, Yen FL, Wu TH, et al. Enhancement of dissolution and antioxidant activity of kaempferol using a nanoparticle engineering process. J Agric Food Chem. 2011;59(9):5073-5080.
66. Nie H, Lee LY, Tong H, Wang CH. PLGA/chitosan composites from a combination of spray drying and supercritical fluid foaming techniques: new carriers for DNA delivery. J Control Release. 2008;129(3): 207-214.
67. Makraduli L, Crcarevska MS, Geskovski N, Dodov MG, Goracinova K. Factorial design analysis and optimisation of alginate-Ca-chitosan microspheres. J Microencapsul. Epub July 3, 2012.
68. Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148(2):135-146.
69. Lee ES, Oh KT, Kim D, Youn YS, Bae YH. Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly-(ethylene glycol)-b-poly(L-histidine). J Control Release. 2007;123(1):19-26.
70. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54(5):631-651.
71. Tan JP, Wang Q, Tam KC. Control of burst release from nanogels via layer by layer assembly. J Control Release. 2008;128(3):248-254.
72. Mehta AK, Yadav KS, Sawant KK. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation. Curr Drug Deliv. 2007;4(3): 185-193.
73. Korsmeyer RW, Gurney R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymer. J Pharm Sci. 1983; 15(1):25-35.
74. Orallo F. Comparative studies of the antioxidant effects of cisand trans-resveratrol. Curr Med Chem. 2006;13(1):87-98.
75. Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58(15):1688-1713.
76. Lemoine D, Francois C, Kedzierewicz F, Preat V, Hoffman M, Maincent P. Stability study of nanoparticles of poly(ε-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials. 1996;17(22):2191-2197.